mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
1e-05 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
6e-05 |